Outcome of Oncology Patients Infected With Coronavirus.
Identifieur interne : 000146 ( PubMed/Curation ); précédent : 000145; suivant : 000147Outcome of Oncology Patients Infected With Coronavirus.
Auteurs : Abdul-Rahman Jazieh [Arabie saoudite] ; Thamer H. Alenazi [Arabie saoudite] ; Ayman Alhejazi [Arabie saoudite] ; Faisal Al Safi [Arabie saoudite] ; Ashwaq Al Olayan [Arabie saoudite]Source :
- JCO global oncology [ 2687-8941 ] ; 2020.
Abstract
This study investigated the features of oncology patients with confirmed Middle East respiratory syndrome (MERS) at the Ministry of National Guard Health Affairs-Riyadh during the outbreak of June 2015 to determine the clinical course and outcome of affected patients.
DOI: 10.1200/GO.20.00064
PubMed: 32196389
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000146
Links to Exploration step
pubmed:32196389Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Outcome of Oncology Patients Infected With Coronavirus.</title><author><name sortKey="Jazieh, Abdul Rahman" sort="Jazieh, Abdul Rahman" uniqKey="Jazieh A" first="Abdul-Rahman" last="Jazieh">Abdul-Rahman Jazieh</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh</wicri:regionArea></affiliation></author><author><name sortKey="Alenazi, Thamer H" sort="Alenazi, Thamer H" uniqKey="Alenazi T" first="Thamer H" last="Alenazi">Thamer H. Alenazi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh</wicri:regionArea></affiliation></author><author><name sortKey="Alhejazi, Ayman" sort="Alhejazi, Ayman" uniqKey="Alhejazi A" first="Ayman" last="Alhejazi">Ayman Alhejazi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh</wicri:regionArea></affiliation></author><author><name sortKey="Al Safi, Faisal" sort="Al Safi, Faisal" uniqKey="Al Safi F" first="Faisal" last="Al Safi">Faisal Al Safi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh</wicri:regionArea></affiliation></author><author><name sortKey="Al Olayan, Ashwaq" sort="Al Olayan, Ashwaq" uniqKey="Al Olayan A" first="Ashwaq" last="Al Olayan">Ashwaq Al Olayan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32196389</idno><idno type="pmid">32196389</idno><idno type="doi">10.1200/GO.20.00064</idno><idno type="wicri:Area/PubMed/Corpus">000146</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000146</idno><idno type="wicri:Area/PubMed/Curation">000146</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000146</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Outcome of Oncology Patients Infected With Coronavirus.</title><author><name sortKey="Jazieh, Abdul Rahman" sort="Jazieh, Abdul Rahman" uniqKey="Jazieh A" first="Abdul-Rahman" last="Jazieh">Abdul-Rahman Jazieh</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh</wicri:regionArea></affiliation></author><author><name sortKey="Alenazi, Thamer H" sort="Alenazi, Thamer H" uniqKey="Alenazi T" first="Thamer H" last="Alenazi">Thamer H. Alenazi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh</wicri:regionArea></affiliation></author><author><name sortKey="Alhejazi, Ayman" sort="Alhejazi, Ayman" uniqKey="Alhejazi A" first="Ayman" last="Alhejazi">Ayman Alhejazi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh</wicri:regionArea></affiliation></author><author><name sortKey="Al Safi, Faisal" sort="Al Safi, Faisal" uniqKey="Al Safi F" first="Faisal" last="Al Safi">Faisal Al Safi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh</wicri:regionArea></affiliation></author><author><name sortKey="Al Olayan, Ashwaq" sort="Al Olayan, Ashwaq" uniqKey="Al Olayan A" first="Ashwaq" last="Al Olayan">Ashwaq Al Olayan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh</wicri:regionArea></affiliation></author></analytic><series><title level="j">JCO global oncology</title><idno type="eISSN">2687-8941</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study investigated the features of oncology patients with confirmed Middle East respiratory syndrome (MERS) at the Ministry of National Guard Health Affairs-Riyadh during the outbreak of June 2015 to determine the clinical course and outcome of affected patients.</div></front></TEI><pubmed><MedlineCitation Status="In-Data-Review" Owner="NLM"><PMID Version="1">32196389</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2687-8941</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>JCO global oncology</Title><ISOAbbreviation>JCO Glob Oncol</ISOAbbreviation></Journal><ArticleTitle>Outcome of Oncology Patients Infected With Coronavirus.</ArticleTitle><Pagination><MedlinePgn>471-475</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1200/GO.20.00064</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This study investigated the features of oncology patients with confirmed Middle East respiratory syndrome (MERS) at the Ministry of National Guard Health Affairs-Riyadh during the outbreak of June 2015 to determine the clinical course and outcome of affected patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The patients' demographic information, cancer history, treatment pattern, information about MERS-coronavirus (CoV) infection, history of travel, clinical symptoms, test results, and outcome were collected and analyzed as part of a quality improvement project to improve the care and safety of our patients. Only patients with confirmed infection were included.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 19 patients were identified, with a median age of 66 years (range, 16-88 years), and 12 patients (63%) were males. The most common underlying disease was hematologic malignancies (47.4%), followed by colorectal cancer (21%) and lung cancer (15.8%). Hypertension and diabetes mellitus were the most common comorbidities (57.9% and 52.6%, respectively). Infection was diagnosed by nasopharyngeal swab in all patients. All patients contracted the infection during their hospitalization for other reasons. Sixteen patients (80%) were admitted to the intensive care unit; 13 patients (81%) had acute respiratory distress syndrome, 11 were intubated (68.75%), 9 had acute renal injury (56.25%), and 3 required dialysis (18.75%). Only 3 patients (15.8%) with early-stage cancers survived. Patients with hematologic malignancies and advanced solid tumors had a 100% case fatality rate. The majority of the causes of death were due to multi-organ failure and septic shock.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">MERS-CoV infection resulted in a high case fatality rate in patients with malignancy. Therefore, it is critical to implement effective primary preventive measures to avoid exposure of patients with cancer to the virus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jazieh</LastName><ForeName>Abdul-Rahman</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alenazi</LastName><ForeName>Thamer H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhejazi</LastName><ForeName>Ayman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Safi</LastName><ForeName>Faisal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Olayan</LastName><ForeName>Ashwaq</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCO Glob Oncol</MedlineTA><NlmUniqueID>101760170</NlmUniqueID><ISSNLinking>2687-8941</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32196389</ArticleId><ArticleId IdType="doi">10.1200/GO.20.00064</ArticleId><ArticleId IdType="pmc">PMC7124938</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Infect Control Hosp Epidemiol. 2016 Oct;37(10):1147-55</Citation><ArticleIdList><ArticleId IdType="pubmed">27426423</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Ann Saudi Med. 2015 May-Jun;35(3):203-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26409794</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2015 Nov;21(11):2088-90</Citation><ArticleIdList><ArticleId IdType="pubmed">26488869</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Virol Sin. 2016 Feb;31(1):81-4</Citation><ArticleIdList><ArticleId IdType="pubmed">26826080</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2013 Sep;13(9):752-61</Citation><ArticleIdList><ArticleId IdType="pubmed">23891402</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Int J Infect Dis. 2014 Dec;29:301-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25303830</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2013 Aug 1;369(5):407-16</Citation><ArticleIdList><ArticleId IdType="pubmed">23782161</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Bone Marrow Transplant. 1989 Jan;4(1):35-40</Citation><ArticleIdList><ArticleId IdType="pubmed">2647186</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Int J Infect Dis. 2016 Aug;49:129-33</Citation><ArticleIdList><ArticleId IdType="pubmed">27352628</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4956-4961</Citation><ArticleIdList><ArticleId IdType="pubmed">30070331</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Sci Rep. 2019 May 14;9(1):7385</Citation><ArticleIdList><ArticleId IdType="pubmed">31089148</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000146 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000146 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:32196389
|texte= Outcome of Oncology Patients Infected With Coronavirus.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32196389" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |